Closed Systems Drug Transfer Devices Market

The closed system drug transfer devices provide protection against hazardous drugs or vapors during drug preparation and administration. It comprises components which enables filtering of dangerous vapors out of the system. Closed system drug transfer devices play a major role in protection of healthcare professionals from antineoplastic as well as other harmful medications.

Closed Systems Drug Transfer Devices Market contains market size and forecasts of Closed Systems Drug Transfer Devices in global, including the following market information:

• Global Closed Systems Drug Transfer Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Closed Systems Drug Transfer Devices Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Closed Systems Drug Transfer Devices companies in 2021 (%)

The global Closed Systems Drug Transfer Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Membrane-to-Membrane Systems Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Closed Systems Drug Transfer Devices include B. Braun Medical Inc, Victus, Inc, BD, Equashield, ICU MEDICAL INC., Simplivia Healthcare Ltd., Caragen Ltd, Yukon Medical and Corvida and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Closed Systems Drug Transfer Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Closed Systems Drug Transfer Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Closed Systems Drug Transfer Devices Market Segment Percentages, by Type, 2021 (%)

• Membrane-to-Membrane Systems
• Needleless Systems

Global Closed Systems Drug Transfer Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Closed Systems Drug Transfer Devices Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Clinics
• Oncology Centers
• Others

Global Closed Systems Drug Transfer Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Closed Systems Drug Transfer Devices Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Closed Systems Drug Transfer Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Closed Systems Drug Transfer Devices revenues share in global market, 2021 (%)
• Key companies Closed Systems Drug Transfer Devices sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Closed Systems Drug Transfer Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• B. Braun Medical Inc
• Victus, Inc
• BD
• Equashield
• ICU MEDICAL INC.
• Simplivia Healthcare Ltd.
• Caragen Ltd
• Yukon Medical
• Corvida
• JMS